DAVID
NAVARRO ORTEGA
CATEDRÁTICO/A DE UNIVERSIDAD
University of Rome Tor Vergata
Roma, ItaliaUniversity of Rome Tor Vergata-ko ikertzaileekin lankidetzan egindako argitalpenak (5)
2022
2017
-
Pathogen reduction/inactivation of products for the treatment of bleeding disorders: what are the processes and what should we say to patients?
Annals of Hematology, Vol. 96, Núm. 8, pp. 1253-1270
2016
-
Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders
Blood Reviews, Vol. 30, Núm. 1, pp. 35-48
2013
-
Pathogen safety of long-term treatments for bleeding disorders: (Un)Predictable risks and evolving threats
Seminars in Thrombosis and Hemostasis, Vol. 39, Núm. 7, pp. 779-793
-
Pathogen safety of long-term treatments for bleeding disorders: Still relevant to current practice
Haematologica